Boliden AB (BOL)
Nasdaq Stockholm · Sweden · prices in SEK · close of 27 Oct 2026
Key indicators
| Last close | SEK 507.60 |
|---|---|
| 52-week range | 403.40 – 727.80 |
| Return, 1 month / 3 months | −2.6% / +7.1% |
| Return, 1 year / 3 years | +21.9% / +87.0% |
| Trend | Below its 200-day average |
| RSI (14) | 46 |
| Volatility (1 year) | 46.6% |
| Worst drawdown (1 year) | -35.8% |
| Average daily value traded | 568.16M SEK |
| Dividend yield | 2.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Boliden AB is a Swedish mining and metals company based in Stockholm. It extracts ore from its own mines, chiefly copper, zinc, lead, gold and silver, and operates smelters that refine these metals into products for industrial customers around the world. Its operations span mining, smelting and metal recycling, serving manufacturers and other businesses that need refined base and precious metals.
Boliden AB trades under the code BOL on the Nasdaq Stockholm in Sweden, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Boliden AB (BOL) trades on the Nasdaq Stockholm in Sweden. It last closed at SEK 507.60 on 27 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 299 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 21.9% and over the last three months it rose 7.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Stockholm
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 47 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -7.6% | ||
| From 52-week high | -29.8% | ||
| Momentum | 72 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 7.1% | ||
| 6-month return | 1.1% | ||
| 12-month return, skipping the last month | 25.2% | ||
| Stability (higher is calmer) | 57 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 46.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -35.8% | ||
| Liquidity | 99 · Strong | Trades actively. | |
| Average daily value traded | 568.16M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 33 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.2% | ||
| Years with dividends | 4 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.1% |
|---|---|
| 1 month | −2.6% |
| 3 months | +7.1% |
| 6 months | +1.1% |
| 1 year | +21.9% |
| 3 years | +87.0% |
| 5 years | +108.2% |
Signals
| 50-day / 200-day average | 534.47 / 549.38 |
|---|---|
| Golden / death cross (60 days) | Death, 57 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 17.52 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Apr 2026 | SEK 11.0000 |
| 24 Apr 2024 | SEK 7.5000 |
| 9 May 2023 | SEK 11.5000 |
| 26 Apr 2023 | SEK 14.5348 |
| 29 Apr 2022 | SEK 9.7560 |
| 28 Apr 2021 | SEK 7.5317 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Stockholm; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.